Clinical Trial Update: Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating imatinib for Loa loa shows terminated status with posted results addressing efficacy and microfilaricidal kinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Loiasis

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Loiasis | Phase 2 | Status: TERMINATED | Results posted: 2022-06-07